Payment Type: | T/T,L/C |
---|---|
Min. Order: | 1 Gram |
Model No.: 864070-44-0
Brand: Conbottpharm
Packaging: As required
Productivity: Customized
Transportation: Ocean,Air
Place of Origin: China
Supply Ability: Commercial
Certificate: Documents Support
Payment Type: T/T,L/C
Backed by a professional team, we recommend a high quality Empagliflozin CAS 864070-44-0 to client with great enthusiasm. Empagliflozin is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. Empagliflozin, we supply, is processed under safe formulation and repeated test by our experts. We are capable to offer high purity Empagliflozin 864070-44-0 to clients.
Thera. Category: SGLT-2 inhibitor, Diabetes drugs
Cas No.: 864070-44-0
Synonym: EMpagliflozin;BI-10773;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol;EMpagliflozin/ BI-10773;EMPAGLIFLBZIN;(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol;D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]M ethyl]phenyl]-, (1S)-;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol Empagliflozin BI 10773
Molecular Formula: C23H27ClO7
Molecular Weight: 450.90928
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Treatment of Diabetes
Related product:
Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. Blocking SGLT-2 causes blood glucose to be eliminated through the urine via the urethra. The Empagliflozin phase III clinical trial program will include about 14,500 patients. The program consists of twelve ongoing international phase III clinical trials, including a large cardiovascular outcomes trial
Product Categories : Inhibitors > SGLT Inhibitors